Document 05.03
Ref. Ares(2019)7622862 - 11/12/2019
FMD Implementation Workshop
Where: Crowne Plaza Hotel Rue Gineste, 3 1210 Bruxel es
Date : 4 December 2019 Time: 11.00h 17.00h
List of
Participants
Name
Company
EFPIA
1.
Bayer
2.
Pfizer
3.
Pierre-Fabre
4.
Otsuka
5.
Takeda
6.
Amgen
7.
AIFP
8.
MSD
9.
ABPI
10.
Roche
11.
Grünenthal
12.
VfA
13.
Ipsen
14.
Novo Nordisk
15.
Otsuka
16.
Novo Nordisk
17.
SfEE
18.
MSD
19.
GSK
20.
Johnson & Johnson
21.
Eisai
22.
Pierre-Fabre
23.
LIF/Denmark
24.
Pierre-Fabre
25.
Biogen
26.
Sanofi
27.
BMS
28.
Menarini
29.
UCB
30.
Boehringer-Ingelheim
31.
GlaxoSmithKline
32.
Biogen
33.
Amgen
34.
Merck
35.
AstraZeneca
36.
UCB
EFPIA Secretariat
37.
EFPIA
38.
EFPIA
EMVO
39.
EMVO
40.
EMVO
41.
EMVO
42.
EMVO
43.
EMVO
Medicines for Europe
44.
Mylan
45.
Zentiva
46.
Novartis
47.
Fresenius
48.
Alkaloid
49.
CIPLA
50.
Fresenius-Kabi
51.
Fresenius Kabi
52.
Teva
53.
Assogenerici
54.
Instinctif
55.
Medicines for Europe
56.
Instinctif
GIRP
57.
GIRP
58.
GIRP
59.
McKesson Europe AG
EAEPC
60.
EAEPC
HOPAL
61.
Hopal
PGEU
62.
PGEU
NMVOS
63.
Securmed
64.
HLL/Malta
65.
IMVO
66.
BeMVO
67.
Lzvo
68.
MAMVO
69.
SEVEM
70.
SMVO
71.
FIMVO
72.
Sool
73.
DMVO
74.
Koef
75.
LMVO
76.
NMVO/Pl
77.
AMVS
78.
Kowal
79.
Nomvec
80.
NVVO
81.
Zapaz
82.
BGMVO
83.
CZMVO
84.
ICEMVO
85.
MVO Portugal
86.
E-vis.se
87.
SMVO
88.
NMVO/Nl